Recalls / Firms / Daiichi Sankyo Pharma Development
Daiichi Sankyo Pharma Development
8 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2014-07-12 | Class II | Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/12.5 mg, 30 count bot | Terminated |
| 2014-07-12 | Class II | Benicar Tablets (olmesartan medoxomil) 40 mg, 30 and 90 count, Rx Only Manufactured for: D | Terminated |
| 2014-07-12 | Class II | Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 coun | Terminated |
| 2014-07-12 | Class II | Benicar Tablets (olmesartan medoxomil) 20 mg, 30 and 90 count, Rx Only Manufactured for: D | Terminated |
| 2014-07-12 | Class II | Benicar HCT Tablets (olmesartan medoxomil, hydrochlorothiazide) 20 mg/12.5 mg, 30 count bo | Terminated |
| 2014-07-12 | Class II | Tribenzor Tablets (olmesartan medoxomil/amlodipine/hydrochlorothiazide), 40 mg/5 mg*/25 mg | Terminated |
| 2014-07-12 | Class II | Azor Tablets (amlodipine and olmesartan medoxomil) 10 mg*/40 mg, 30 count bottles, Rx Only | Terminated |
| 2014-07-12 | Class II | Welchol Tablets (colesevelam HCl) 625 mg, 180 count bottles, Rx Only, Manufactured for: Da | Terminated |